The clincal manifestations of mitochondrial encephalomyopathy are described in four generations of a single kindred.
associated features.
Methods
Following identification of the proband, 14 of 24 living members of the family were examined by a neurologist (DC). CT scans were performed on 11 patients, audiometry on seven and EMG/nerve conduction studies on five. Blood glucose levels were measured in 10 patients, C-peptides, pyruvate and lactate levels in six patients. CSF pyruvate and lactate levels were measured in two patients.
Open muscle biopsies were performed in eight patients. These were examined with standard light microscopy, histochemistry and electron microscopy. The histochemical studies were performed on fresh frozen muscle obtained, under local anaesthesia, from the vastus lateralis or the deltoid muscle. Routine stains were performed including H and E; myofibrillar ATPase at pH 9-4, 4-6 and 4-3; NADH; succinate dehydrogenase; PAS; Sudan black; phosphorylase; Gomorri trichrome and acid phosphatase. Staining for cytochrome C oxidase was performed on some of the later biopsies.
The biochemical studies were performed using standard methods.9 A total of 250 muscle biopsies from a referral centre for neuromuscular disease, which were normal on routine histochemical stains, were used as controls. The mean and two standard deviations for each assay were calculated. Total cell DNA was extracted from muscle biopsy specimens in all cases. Polymerase Chain Reaction (PCR) amplification and restriction enzyme analysis was used to probe for mt DNA mutations. The nucleotide (nt) 3243A-G mutation (MELAS)I0 was sought using a primer pair BLF corresponding to nt 2826-2849 of the light strand and ND2H corresponding to nt 5459 to 5482 of the heavy strand. The alternative MELAS mutation (A-G ntpos 11084) and the MERRF mutation (A-G ntpos 8344) were probed for as previously described.l 12 trophoresed DNA was then transferred onto a nylon membrane, hybridised with the appropriate mt DNA fragment probe following random-prime labelling with (32P)dATP and visualised after exposure to Fuji Rx X-ray film at 70°C.
Results
The family pedigree is shown in fig 1 and the clinical features are detailed in table 1 (a, b, c). It is apparent from these that the severity of the disease and the age of onset varied considerably within the kindred. We describe the case histories of a mother and two daughters, who were severely affected. 3) . Cerebral digital subtraction angiography was normal and an EEG showed diffuse 0-5-1 5 Hz delta activity.
As the patient's conscious level improved over the next few weeks, marked truncal and gait ataxia and a coarse postural and intention tremor of the left upper limb were noted. Continuous myoclonic jerks were visible in the abdominal muscles. The cerebellar signs resolved within a few months but the myoclonic jerks have persisted ever since.
The patient was admitted to hospital on a number of occasions over the next two years with episodes of severe headache. On one occasion this was associated with a right homonymous hemianopia which persisted for several months but then resolved completely. Twice during 1986 she was readmitted for bowel pseudo-obstruction secondary to faecal impaction. 
Her sight returned to normal over the next four weeks. An EEG showed generalised slow wave activity. She had had a normal birth and development had been normal.
Over the next three years the patient had numerous admissions to hospital for status epilepticus, and episodes of dysphasia, right sided weakness, vomiting and throbbing frontal headache. In
In 1979 the patient stopped attending school because of progressive cognitive impairment and increasing lethargy. By the end of the year, she was unable to feed herself. A CT scan showed multiple low density lesions in both cerebral hemispheres, with dilatation of the ventricular system. The patient's condition continued to deteriorate with dementia, lethargy, incontinence of urine and faeces, weakness, vomiting, headaches, and fits which became increasingly resistant to medication. The patient died in August 1982.
MUSCLE BIOPSY FINDINGS
Musce morphology, histochemistry and biochemistry Open muscle biopsies were performed in eight patients of which seven were abnormal. Abnormalities varied in severity from minor changes (with only occasional fibres showing mitochondrial disorganisation or sub-sarcolemmal aggregation on succinate dehydrogenase and Gomorri trichrome stains) to marked changes (including generalised fibre atrophy with some fibres undergoing degeneration and up to 20% of the fibres showing and IV, 4). There was no evidence of the alternative A-G MELAS mutation (nt 11084) or the A-G 8344 (MERRF) mutation in any of the cases. A full investigation of the mitochondrial genome in symptomatic and asymptomatic members of this family is now in progress and will be reported separately.
The results of the muscle biochemistry on crude extract are seen in table 2. Four of the patients had cytochrome "C" oxidase deficiency.
Serum lactate and pyruvate levels Table 3 shows the serum pyruvate and lactate levels for the group. Five patients had elevated pyruvate levels and three had elevated lactate levels.
Muscle biopsy biochemistry
In three patients a cytochrome C oxidase deficiency was demonstrated. One other patient had borderline cytochrome C oxidase deficiency. Normal mitochondrial enzyme activity was demonstrated in the other patients studied.
Electron microscopy The muscle biopsies examined by electron microscopy showed abnormalities varying from severe to mild. Severe cases showed myofibrillar degeneration with patchy loss and thinning of the myofibrils and associated increase in glycogen; in these areas the mitochrondria tended to be pleomorphic. In some cases, there were increased numbers of lipid vacuoles and occasionally some dilatation of the sarcoplasmic reticulum. Some fibres had aggregates of mitochondria, pleomorphic and with inclusions, beneath the sarcolemmal membrane.
The inclusions were constant in appearance within this family and consisted of round, uniformly stained, moderately dense bodies without a limiting membrane or obvious internal structure. Paracrystalline or "parking lot" inclusions were not seen. The inclusions varied in number from case to case and correlated with the severity of the other changes. In the more severely affected cases, numerous mitochondria within an affected fibre would contain an inclusion, occasionally more than one; in the mildly affected cases only an occasional mitochondrion with an inclusion could be seen and then only after a careful search.
Discussion
There seems little doubt of the diagnosis of mitochondrial encephalomyopathy in this family. Ten members had clinical features known to be associated with this disorder; a maternal pattern of inheritance could be shown over four generations; seven members had evidence of mitochondrial abnormalities on muscle biopsy; a mitochondrial point mutation was detected in the two cases which were examined. Of interest in this kindred is the diversity of clinical expression in members, all of whom presumably had the same mitochondrial mutation. The index case had episodes of status epilepticus associated with major neurological deficits beginning in adolescence. By contrast, the only clinical evidence of the disease in case III,1, a man of middle age, was deafness and diabetes. In case II,5 myopathy, peripheral neuropathy, dementia and an extrapyramidal disorder had their onset in late middle age.
Severely affected patients had a distinctive presentation. Typically, an attack would begin with a severe, unilateral, throbbing headache associated with vomiting and in some cases constipation. hours, the patients developed generalised tonicclonic seizures usually leading to status epilepticus. Two patients became comatose without preceding convulsions and were found, on electroencephalography, to be in non-convulsive status epilepticus (IV,4 and III,2). On recovery of consciousness, a neurological deficit, such as homonymous hemianopia, dysphasia, hemiparesis or cerebellar ataxia, was apparent. The cerebral CT scan at this time revealed low density lesions which fitted no single vascular territory. These were not associated with cerebral or extracranial angiographic abnormalities, a finding consistent with other reports."3 The recovery from neurological deficits which, on both clinical and radiological grounds were severe, was often surprisingly good. In this kindred, acute neurological deficits were usually accompanied by fits. The term "stroke-like" episode, often used to describe such attacks78 does not convey an accurate picture of their presentation. Similarly, the epilepsy which occurs in these patients is unusual in that it is characterised by episodes of status epilepticus separated by relatively fit-free intervals."3 A number of patients within this kindred had features of mitochondrial encephalomyopathy which were not readily apparent. Deafness was present in 11, basal ganglia calcification (on CT scanning) in eight, short stature in two, severe constipation in five, peptic ulceration in five, non-insulin dependent diabetes in six and migraine in five. Some of these features are common and therefore could be coincidental; all, however, appeared in a pattern consistent with mitochondrial inheritance and an association with ME, with the exception of peptic ulceration, has been described in previous studies.78 "-" It seems unlikely that the deafness was coincidental for it always began in childhood or early adulthood. Basal ganglia calcification occurs in only 0-23-1-6% of patients16-18 and non-insulin dependent diabetes in 1-2%. '9 The constipation which occurred in this kindred was severe enough in itself to warrant hospital admission in three patients (IV,4, II,3 and II,1). Patient II,1 had recurrent bouts of severe constipation beginning in her 30s and culminating in death from pseudoobstruction of the bowel at the age of 78. Severe constipation, associated with mitochondrial myopathy has been reported by others.20 Rather than listing these as associated features of mitochondrial encephalomyopathy it is probably more correct to view them as an integral part of a multi-system disease, a mitochondrial cytopathy.
There are difficulties in fitting this kindred into the current classification of mitochondrial encephalomyopathy.'782' The index case and patient IV,5 had features of MELAS: acute neurological deficits, epilepsy, lactic acidaemia and mitochondrial changes on muscle biopsy. 'he index case, however, also had myoclonus and cerebellar ataxia, features more consistent with MERRF.6 Patient IV,5 had retinal changes and a heart conduction defect, features associated with Kearns Sayre syndrome.4 The major manifestation of the disease in patient II,5 was of a mitochondrial myopathy with proximal weakness, ptosis and external ophthalmoplegia. In addition, he had deafness, peripheral neuropathy, extrapyramidal signs and ataxia. In this kindred there was also marked variability in the age of onset of major symptoms; the youngest presented at three years, the oldest at 70 and four presented after the age of 40.
Others have also been struck by the variability of clinical features and age of onset within a single kindred. In reviewing 90 patients with proven mitochondrial myopathy, Petty et The nt 3243 A-G mutation identified in this family is identical to that reported in the majority of MELAS families in Japan.'0 It has also been encountered in at least one other Australian family. It is not present in all Australian cases; an alternative A-G transition mutation at nt 11084 has been identified in one MELAS family who lack the nt 3243 mutation."
Mitochondrial encephalomyopathy is probably under-recognised, particularly in its minor manifestations. Many of its features are common and readily attributable to other causes. It should be considered in the following circumstances: 1) Major manifestations: patients presenting with an acute "stroke"-like episode with these additional features: a) status epilepticus, convulsive or non-convulsive; b) onset in childhood or early adulthood; c) familial deafness and/or diabetes mellitus d) short stature; e) severe headache, vomiting and constipation; f) calcification of the basal ganglia on CT scan.
2) Minor manifestations: patients presenting with one or more of the following constellation: a) familial deafness; b) diabetes mellitus; c) intractable constipation; d) myopathy (a major manifestation in some patients); e) possibly migraine and familial peptic ulceration.
Having considered the diagnosis, confirmation depends upon the demonstration of abnormal mitochondria on muscle biopsy, or identification of a mitochondrial DNA mutation. Unfortunately, as exemplified by the proband, the patchy distribution of the abnormality may lead to a negative result on muscle biopsy. Paradoxically, muscle abnormalities may be most striking in older patients some of whom have only minor manifestations of the disease.
